All Hands on Deck: A synchronized whole-of-world approach for COVID-19 mitigation.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 20 05 2020
revised: 10 06 2020
accepted: 13 06 2020
pubmed: 23 6 2020
medline: 20 9 2020
entrez: 23 6 2020
Statut: ppublish

Résumé

The COVID-19 pandemic can no longer be mitigated by a nationwide approach of individual nations alone. Given its scale and accelerating expansion, COVID-19 requires a coordinated and simultaneous Whole- of-World approach that galvanizes clear global leadership and solidarity from all governments of the world. Considering an 'all hands-on deck' concept, we present a comprehensive list of tools and entities responsible for enabling them, as well a conceptual framework to achieve the maximum impact. The list is drawn from pandemic mitigation tools developed in response to past outbreaks including influenza, coronaviruses, and Ebola, and includes tools to minimize transmission in various settings including person-to-person, crowd, funerals, travel, workplace, and events and gatherings including business, social and religious venues. Included are the roles of individuals, communities, government and other sectors such as school systems, health, institutions, and business. While individuals and communities have significant responsibilities to prevent person-to-person transmission, other entities can play a significant role to enable individuals and communities to make use of the tools. Historic and current data indicate the role of political will, whole-of-government approach, and the role of early introduction of mitigation measures. There is also an urgent need to further elucidate the immunologic mechanisms underlying the epidemiological characteristics such as the low disease burden among women, and the role of COVID-19 in inducing Kawasaki-like syndromes in children. Understanding the role of and development of anti-inflammatory strategies based on our understanding of pro-inflammatory cytokines (IL1, IL-6) is also critical. Similarly, the role of oxygen therapy as an anti-inflammatory strategy is evident and access to oxygen therapy should be prioritized to avoid the aggravation of COVID-19 infection. We highlight the need for global solidarity to share both mitigation commodities and infrastructure between countries. Given the global reach of COVID-19 and potential for repeat waves of outbreaks, we call on all countries and communities to act synergistically and emphasize the need for synchronized pan-global mitigation efforts to minimize everyone's risk, to maximize collaboration, and to commit to shared progress.

Identifiants

pubmed: 32565364
pii: S1201-9712(20)30484-7
doi: 10.1016/j.ijid.2020.06.049
pmc: PMC7301799
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

208-215

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Science. 2014 Nov 21;346(6212):991-5
pubmed: 25414312
Swiss Med Wkly. 2020 Mar 16;150:w20224
pubmed: 32176808
Lancet. 2020 Mar 14;395(10227):e48
pubmed: 32113506
J Biol Regul Homeost Agents. 2020 Mar 31;34(2):333-338
pubmed: 32228825
Int J Equity Health. 2020 Mar 21;19(1):41
pubmed: 32199457
J Biol Regul Homeost Agents. 2020 Mar 14;34(2):327-331
pubmed: 32171193
Nature. 2020 Mar 18;:
pubmed: 32203363
J Biol Regul Homeost Agents. 2020 Jun 1;34(3):767-773
pubmed: 32476380
JAMA. 2020 Apr 21;323(15):1502-1503
pubmed: 32105304
Lancet. 2020 Apr 4;395(10230):1109-1110
pubmed: 32199470
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Clin Med. 2020 Feb 24;9(2):
pubmed: 32102279
BMJ. 2020 Mar 17;368:m1066
pubmed: 32184233
Bull Math Biol. 2020 Apr 8;82(4):52
pubmed: 32270376
J Biol Regul Homeost Agents. 2020 Apr 07;34(2):339-343
pubmed: 32253888
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32052841
JAMA. 2020 Apr 14;323(14):1341-1342
pubmed: 32125371

Auteurs

Shahul H Ebrahim (SH)

University of Sciences, Technique and Technology, Bamako, Mali. Electronic address: ebrahimsh2@gmail.com.

Jiatong Zhuo (J)

Guangxi Centers for Disease Control Prevention, Nanning, China. Electronic address: Zjta28@168.com.

Ernesto Gozzer (E)

Universidad Peruana Cayetano Heredia, Lima, Peru. Electronic address: Ernesto.gozzer@upch.pe.

Qanta A Ahmed (QA)

Division of Pulmonary Disease and Critical Care Medicine, Department of Medicine, Winthrop University Hospital, Mineola, NY, USA. Electronic address: qanta.ahmed@gmail.com.

Rubina Imtiaz (R)

Children Without Worms, Task Force for Global Health, Decatur, GA, USA. Electronic address: rimtiaz@taskforce.org.

Yusuf Ahmed (Y)

University Teaching Hospitals Associate Professor, Levy Mwanawasa Medical University, Lusaka, Zambia. Electronic address: Yusufahmed03@hotmail.com.

Seydou Doumbia (S)

Faculty of Medicine and Odontostomatology, Director, University Clinical Research Center, University of Sciences, Technique and Technology, Bamako, Mali. Electronic address: sdoumbi@gmail.com.

N M Mujeeb Rahman (NM)

MES Medical College Hospital, Perinthalmanna, India. Electronic address: drnmmujeeb@mesams.com.

Habida Elachola (H)

Mercer University, Atlanta, USA. Electronic address: habidaec@gmail.com.

A Wilder-Smith (A)

Department of Disease Control, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: anneliesws@gmail.com.

Ziad A Memish (ZA)

Research Innovation Center, King Saud Medical City, Ministry of Health and College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA. Electronic address: zmemish@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH